Retrieve available abstracts of 74 articles: HTML format
Single Articles
January 2025
MOONEN CPB, Brouwers EEHG, Hoebe CJPA, Dukers-Muijrers NHTM, et al Reaching Syrian migrants through Dutch municipal registries for hepatitis B and C
point-of-care testing.
PLoS One. 2025;20:e0316726. PubMedAbstract available
ADJEI-GYAMFI S, Asirifi A, Asobuno C, Korang FK, et al Knowledge and occupational practices of beauticians and barbers in the
transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana.
PLoS One. 2025;20:e0306961. PubMedAbstract available
PATIL A, Vidhate P, Patil S, Rao A, et al Looking back into the Hepatitis C Virus epidemic dynamics from Unnao, India
through phylogenetic approach.
PLoS One. 2025;20:e0317705. PubMedAbstract available
ZUBAIR S, Parvaiz F, Abualait T, Al-Regaiey K, et al Computational design of multi-epitope vaccine against Hepatitis C Virus infection
using immunoinformatics techniques.
PLoS One. 2025;20:e0317520. PubMedAbstract available
Expression of Concern: Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal
Degradation in Free Fatty Acid Treated HCV Cell Culture.
PLoS One. 2025;20:e0319262. PubMed
ELIAH DT, Chamba NG, Sadiq AM, Mwasamwaja AO, et al Seroprevalence and associated factors for hepatitis B and hepatitis C viral
infection among patients with diabetes mellitus in Northern Tanzania.
PLoS One. 2025;20:e0319198. PubMedAbstract available
TORIU N, Sato Y, Kamimura H, Yoshikawa T, et al Aligning cellular and molecular components in age-dependent tertiary lymphoid
tissues of kidney and liver.
PLoS One. 2025;20:e0311193. PubMedAbstract available
Expression of Concern: Impaired expression of type I and type II interferon
receptors in HCV-associated chronic liver disease and liver cirrhosis.
PLoS One. 2025;20:e0320610. PubMed
PAWLOWSKI T, Radkowski M, Perlejewski K, Szymanska B, et al Direct-acting antivirals (DAA) positively affect depression and cognitive
function in patients with chronic hepatitis C.
PLoS One. 2025;20:e0320221. PubMedAbstract available
LI J, He J, Yang G, Cao Z, et al Influencing factors of HCV testing willingness among men who have sex with men in
China: A structural equation modeling analysis.
PLoS One. 2025;20:e0321469. PubMedAbstract available
BAKIC M, Stevanovic J, Milic M, Galic I, et al Factors associated with the prevalence of viral hepatitis B and C among
prisoners: Results of two consecutive national surveys in Montenegro.
PLoS One. 2025;20:e0321464. PubMedAbstract available
FOSU PK, Hoor GT, Adjei CA, Atibila F, et al Prevalence of Hepatitis C viral infection in Ghana: A systematic review and
meta-analysis protocol.
PLoS One. 2025;20:e0321483. PubMedAbstract available
January 2024
DARVISHI-KHEZRI H, Karami H, Naderisorki M, Ghazaiean M, et al Two risk factors for hypozincemia in diabetic beta-thalassemia patients: Hepatitis C
and deferasirox.
PLoS One. 2024;19:e0284267. PubMedAbstract available
KALIBATAS V, Kalibatiene L, Imashpayev D Blood donations and donors' profile in Lithuania: Trends for coming back after
the COVID-19 outbreak.
PLoS One. 2024;19:e0297580. PubMedAbstract available
KENFACK-MOMO R, Ngounoue MD, Kenmoe S, Takuissu GR, et al Global epidemiology of hepatitis C virus in dialysis patients: A systematic
review and meta-analysis.
PLoS One. 2024;19:e0284169. PubMedAbstract available
YEN YH, Kee KM, Hu TH, Tsai MC, et al Hepatitis B virus-related hepatocellular carcinoma has superior overall survival
compared with other etiologies.
PLoS One. 2024;19:e0290523. PubMedAbstract available
DANG X, Hanson BA, Orban ZS, Jimenez M, et al Characterization of the brain virome in human immunodeficiency virus infection
and substance use disorder.
PLoS One. 2024;19:e0299891. PubMedAbstract available
TADESSE K, Ayalew G, Million Y, Gelaw A, et al Hepatitis B and hepatitis C virus infections and associated factors among
prisoners in Gondar City, Northwest Ethiopia.
PLoS One. 2024;19:e0301973. PubMedAbstract available
KIMBALL S, Reynoso M, McKnight C, Des Jarlais D, et al Hepatitis C treatment outcomes among people who inject drugs experiencing
unstable versus stable housing: Systematic review and meta-analysis.
PLoS One. 2024;19:e0302471. PubMedAbstract available
WENDELBOE AM, Naqvi OH, Williams M, Hollen H, et al Opioid and other drug use and drug-related mortality as indicators of Hepatitis C
and Human Immunodeficiency Virus in Oklahoma.
PLoS One. 2024;19:e0301442. PubMedAbstract available
BASIMANE-BISIMWA P, Koyaweda GW, Ngaiganam E, Vickos U, et al Seroprevalence and molecular characterization of viral hepatitis and HIV
co-infection in the Central African Republic.
PLoS One. 2024;19:e0291155. PubMedAbstract available
HAGOS YM, Yalew GT, Meles HN, Tsegay E, et al Hepatitis B and C viral coinfection and associated factors among HIV-positive
patients attending ART clinics of Afar regional state, northeast Ethiopia.
PLoS One. 2024;19:e0302453. PubMedAbstract available
GOLAM RM, Khalil MAF, Shaker OG, Ahmed TI, et al The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the
diagnosis of HCV-related hepatocellular carcinoma.
PLoS One. 2024;19:e0303314. PubMedAbstract available
PEWKLIANG Y, Thongsri P, Suthivanich P, Thongbaiphet N, et al Immortalized hepatocyte-like cells: A competent hepatocyte model for studying
clinical HCV isolate infection.
PLoS One. 2024;19:e0303265. PubMedAbstract available
MIURA M, Nishino M, Kawaguchi K, Li S, et al Programmed cell death-1 is involved with peripheral blood immune cell profiles in
patients with hepatitis C virus antiviral therapy.
PLoS One. 2024;19:e0299424. PubMedAbstract available
GEDEFIE A, Debash H, Asmamaw S, Getaneh FB, et al Epidemiology of an overlapping and parallel infection of Sexually Transmitted
Infections among pregnant women in North-east Ethiopia: Its implication for
prevention of mother to child transmission.
PLoS One. 2024;19:e0300149. PubMedAbstract available
NAM DE, Park SJ, Omole S, Um E, et al Activated Gab1 drives hepatocyte proliferation and anti-apoptosis in liver
fibrosis via potential involvement of the HGF/c-Met signaling axis.
PLoS One. 2024;19:e0306345. PubMedAbstract available
ZEZIULIN O, Kornilova M, Deac A, Morozova O, et al Modes of HIV transmission among young women and their sexual partners in Ukraine.
PLoS One. 2024;19:e0305072. PubMedAbstract available
SIAW ADJ, Amugsi J, Owusu-Konadu MAA, Drah ST, et al Prevalence and risk factors of Hepatitis C virus infection in the Upper East
Region of Ghana; a community-based cross-sectional study.
PLoS One. 2024;19:e0306292. PubMedAbstract available
ATANAW T, Girmay G, Zemene A, Assefa M, et al Seroprevalence of hepatitis B and C viruses and some possible associated factors
among cancer patients at the Oncology Treatment Center, Gondar, Northwest
Ethiopia: A cross-sectional study.
PLoS One. 2024;19:e0308161. PubMedAbstract available
Retraction: Interferon and Ribavirin Combination Treatment Synergistically
Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of
Polyribosome Formation.
PLoS One. 2024;19:e0308579. PubMed
MANGALA C, Maulot-Bangola D, Moutsinga A, Okolongo-Mayani SC, et al Prevalence and factors associated with transfusion-transmissible infections (HIV,
HBV, HCV and Syphilis) among blood donors in Gabon: Systematic review and
meta-analysis.
PLoS One. 2024;19:e0307101. PubMedAbstract available
LEE CSJ, Mateu-Gelabert P, Melendez YA, Fong C, et al Reduced injection risk behavior with co-located hepatitis C treatment at a
syringe service program: The accessible care model.
PLoS One. 2024;19:e0308102. PubMedAbstract available
GUURE C, Dery S, Baptista da Silva C, Asamoah-Adu C, et al Situational assessment and epidemiology of HIV, HBV and HCV among people who use
and inject drugs in Ghana.
PLoS One. 2024;19:e0305923. PubMedAbstract available
MAZUMDER H, Hossain MF, Shrestha P, Mahmud S, et al Prevalence and associated risk factors of current hepatitis C infection among
U.S. general population and injection drug users aged 20-59 years: NHANES
2009-2018.
PLoS One. 2024;19:e0309345. PubMedAbstract available
WANG HW, Wang YC, Huang YT, Jiang MY, et al All-cause and cause-specific mortality risk among men and women with hepatitis C
virus infection.
PLoS One. 2024;19:e0309819. PubMedAbstract available
PHYO Z, Ko K, Ouoba S, Sugiyama A, et al Intermediate hepatitis C virus (HCV) endemicity and its genotype distribution in
Myanmar: A systematic review and meta-analysis.
PLoS One. 2024;19:e0307872. PubMedAbstract available
CHIU I, Cano D, Leathers M, Turner CM, et al HIV and hepatitis C virus infection and co-infection among trans women in San
Francisco, 2020.
PLoS One. 2024;19:e0307990. PubMedAbstract available
ASTLEY J, Saralamba S, Poovorawan K, White LJ, et al Population and transmission dynamics model to determine WHO targets for
eliminating Hepatitis C virus in Thailand.
PLoS One. 2024;19:e0309313. PubMedAbstract available
JIANG J, Shiels MS, Rivera D, Ghany MG, et al Trends in hepatocellular carcinoma and viral hepatitis treatment in older
Americans.
PLoS One. 2024;19:e0307746. PubMedAbstract available
GIRMAY G, Bewket G, Amare A, Angelo AA, et al Seroprevalence of viral hepatitis B and C infections among healthcare workers in
Ethiopia: A systematic review and meta-analysis.
PLoS One. 2024;19:e0312959. PubMedAbstract available
KANOKUDOM S, Poovorawan K, Nilyanimit P, Suntronwong N, et al Comparison of anti-HCV combined with HCVcAg (Elecsys HCV Duo immunoassay) and
anti-HCV rapid test followed by HCV RNA analysis using qRT-PCR to identify active
infection for treatment.
PLoS One. 2024;19:e0313771. PubMedAbstract available
HONGJAISEE S, Khamduang W, Kham-Kjing N, Ngo-Giang-Huong N, et al Seroprevalence and associated factors of HIV, syphilis, hepatitis B, and
hepatitis C infections among sex workers in Chiangmai, Thailand during easing of
COVID-19 lockdown measures.
PLoS One. 2024;19:e0316668. PubMedAbstract available
January 2023
HACK B, Sanghavi K, Gundapaneni S, Fernandez S, et al HCV universal EHR prompt successfully increases screening, highlights potential
disparities.
PLoS One. 2023;18:e0279972. PubMedAbstract available
ZHANG C, Qu Q, Yao Y, Fan X, et al Detection of Hepatitis C virus RNA using a novel hybridization chain reaction
method that competitively dampens cascade amplification.
PLoS One. 2023;18:e0268917. PubMedAbstract available
YU L, Paski SC, Dodge J, Bambha K, et al Effect of dietary branched chain amino acids on liver related mortality: Results
from a large cohort of North American patients with advanced HCV infection.
PLoS One. 2023;18:e0284739. PubMedAbstract available
WEATHERLY M, Trivedi A, Chembrolu R, Gupta S, et al Maternal infections in pregnancy and the risk of sudden unexpected infant death
in the offspring in the U.S., 2011-2015.
PLoS One. 2023;18:e0284614. PubMedAbstract available
YAKOVCHENKO V, Jacob DA, Rogal SS, Morgan TR, et al User experience of a hepatitis c population management dashboard in the
Department of Veterans Affairs.
PLoS One. 2023;18:e0285044. PubMedAbstract available
AWASTHI A, Katiyar H, Rungta S, Deep A, et al Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naive
non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol
for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE
trial).
PLoS One. 2023;18:e0285725. PubMedAbstract available
NAING TS, Yee WW, Aung HT, Oo KY, et al The feasibility and acceptability of integrating hepatitis C and HIV diagnostic
testing on centralized molecular laboratory platforms in Myanmar.
PLoS One. 2023;18:e0282585. PubMedAbstract available
ZANONI BC, Milford C, Sithole K, Mosery N, et al High risk injection drug use and uptake of HIV prevention and treatment services
among people who inject drugs in KwaZulu-Natal, South Africa.
PLoS One. 2023;18:e0281030. PubMedAbstract available
D FREIRE I, L Fielding K, A J Moore D Does diabetes mellitus comorbidity increase the risk of drug-induced liver injury
during tuberculosis treatment?
PLoS One. 2023;18:e0286306. PubMedAbstract available
KUMAR A, Mahajan H, Chaturvedi S, Kumar A, et al Hepatitis C virus seroprevalence among patients enrolled at the opioid
substitution therapy center in Bihar: A cross-sectional study.
PLoS One. 2023;18:e0287333. PubMedAbstract available
NARTEY YA, Okine R, Seake-Kwawu A, Ghartey G, et al Hepatitis C virus seroprevalence, testing, and treatment capacity in public
health facilities in Ghana, 2016-2021; A multi-centre cross-sectional study.
PLoS One. 2023;18:e0287580. PubMedAbstract available
ROSS J, Rupasinghe D, Avihingsanon A, Lee MP, et al Trends in hepatitis C virus coinfection and its cascade of care among adults
living with HIV in Asia between 2010 and 2020.
PLoS One. 2023;18:e0287909. PubMedAbstract available
MONTEIRO IP, Azzi CFG, Bilibio JP, Monteiro PS, et al Prevalence of sexually transmissible infections in adolescents treated in a
family planning outpatient clinic for adolescents in the western Amazon.
PLoS One. 2023;18:e0287633. PubMedAbstract available
HANSOONGNERN P, Pratedrat P, Nilyanimit P, Wasitthankasem R, et al An amino acid substitution in HCV core antigen limits its use as a reliable
measure of HCV infection compared with HCV RNA.
PLoS One. 2023;18:e0287694. PubMedAbstract available
OGUNBAJO A, Brooks M, Oke T, Martinez O, et al Hepatitis C (HCV) among Black and Latino sexual minority men (SMM) in the
Southern United States: Protocol of a prospective cohort epidemiological study.
PLoS One. 2023;18:e0288129. PubMedAbstract available
CHU C, Gomes T, Antoniou T, Wong WWL, et al The impact of expanded access to direct acting antivirals for Hepatitis C virus
on patient outcomes in Canada.
PLoS One. 2023;18:e0284914. PubMedAbstract available
NAGARAJA T, Chen L, Balasubramanian A, Groopman JE, et al Correction: Activation of the Connective Tissue Growth Factor (CTGF)-Transforming
Growth Factor beta 1 (TGF-beta 1) Axis in Hepatitis C Virus-Expressing Hepatocytes.
PLoS One. 2023;18:e0290786. PubMedAbstract available
THI THU PN, Hoang Van D, Ngo Thi Quynh M, Tran Thi N, et al Metabolic, renal, and hematological changes in chronic hepatitis C patients
achieving rapid virologic response after 12 weeks of direct-acting antiviral
treatment: A prospective cohort study.
PLoS One. 2023;18:e0290235. PubMedAbstract available
SCHULER BA, Bastarache L, Wang J, He J, et al Population genetic testing and SERPINA1 sequencing identifies unidentified
alpha-1 antitrypsin deficiency alleles and gene-environment interaction with
hepatitis C infection.
PLoS One. 2023;18:e0286469. PubMedAbstract available
CHAROENKWAN P, Waramit S, Chumnanpuen P, Schaduangrat N, et al TROLLOPE: A novel sequence-based stacked approach for the accelerated discovery
of linear T-cell epitopes of hepatitis C virus.
PLoS One. 2023;18:e0290538. PubMedAbstract available
SCHWARZ M, Schwarz C, Burghart L, Pfisterer N, et al Late-stage presentation with decompensated cirrhosis is alarmingly common but
successful etiologic therapy allows for favorable clinical outcomes.
PLoS One. 2023;18:e0290352. PubMedAbstract available
EJAZ S, Paracha RZ, Ejaz S, Jamal Z, et al Antibody designing against IIIabc junction (JIIIabc) of HCV IRES through affinity
maturation; RNA-Antibody docking and interaction analysis.
PLoS One. 2023;18:e0291213. PubMedAbstract available
YOSHIDA Y, Atsukawa M, Kondo C, Kitamura M, et al A novel formula used for predicting hepatocellular carcinoma after the
achievement of sustained virologic response by direct-acting antivirals in
patients with chronic hepatitis C.
PLoS One. 2023;18:e0292019. PubMedAbstract available
GOINS EC, Wein LE, Watkins VY, Campbell AIK, et al Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic
cholestasis of pregnancy: The sum of the parts.
PLoS One. 2023;18:e0293030. PubMedAbstract available
HOOD RB, Miller WC, Shoben A, Harris RE, et al Maternal hepatitis C virus infection and three adverse maternal outcomes in the
United States.
PLoS One. 2023;18:e0291994. PubMedAbstract available
GNANAPANDITHAN K, Ghali MP Self-awareness of hepatitis C infection in the United States: A cross-sectional
study based on the National Health Nutrition and Examination Survey.
PLoS One. 2023;18:e0293315. PubMedAbstract available
PRINSENBERG T, Illidge J, Zantkuijl P, Bedert M, et al Correction: Usability, acceptability, and self-reported impact of an innovative
hepatitis C risk reduction intervention for men have sex with men: A mixed
methods study.
PLoS One. 2023;18:e0295455. PubMedAbstract available
YE J, Sun Y, Li J, Lu X, et al Distribution pattern, molecular transmission networks, and phylodynamic of
hepatitis C virus in China.
PLoS One. 2023;18:e0296053. PubMedAbstract available
WURCEL AG, Guardado R, Grussing ED, Koutoujian PJ, et al Racial differences in testing for infectious diseases: An analysis of jail intake
data.
PLoS One. 2023;18:e0288254. PubMedAbstract available
January 2021
SCHMIDBAUER C, Schwarz M, Schutz A, Schubert R, et al Directly observed therapy at opioid substitution facilities using
sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for
non-adherence to DAA therapy.
PLoS One. 2021;16:e0252274. PubMedAbstract available